These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 25093975)

  • 1. Temporal trends in mortality and loss to follow-up among children enrolled in Côte d'Ivoire's national antiretroviral therapy program.
    Auld AF; Tuho MZ; Ekra KA; Shiraishi RW; Mohamed F; Kouakou JS; Ettiègne-Traoré V; Sabatier J; Essombo J; Rivadeneira ED; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Pediatr Infect Dis J; 2014 Nov; 33(11):1134-40. PubMed ID: 25093975
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporal trends in treatment outcomes for HIV-1 and HIV-2-infected adults enrolled in Côte d'Ivoire's national antiretroviral therapy program.
    Auld AF; Ekra KA; Shiraishi RW; Tuho MZ; Kouakou JS; Mohamed F; Ettiègne-Traoré V; Sabatier J; Essombo J; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    PLoS One; 2014; 9(5):e98183. PubMed ID: 24866468
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis in human immunodeficiency virus-infected children starting antiretroviral therapy in Côte d'Ivoire.
    Auld AF; Tuho MZ; Ekra KA; Kouakou J; Shiraishi RW; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    Int J Tuberc Lung Dis; 2014 Apr; 18(4):381-7. PubMed ID: 24670690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Scaling up antiretroviral therapy for HIV-infected children in Côte d'Ivoire: determinants of survival and loss to programme.
    Anaky MF; Duvignac J; Wemin L; Kouakoussui A; Karcher S; Touré S; Seyler C; Fassinou P; Dabis F; N'Dri-Yoman T; Anglaret X; Leroy V
    Bull World Health Organ; 2010 Jul; 88(7):490-9. PubMed ID: 20616968
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal Trends in Patient Characteristics and Outcomes Among Children Enrolled in Mozambique's National Antiretroviral Therapy Program.
    Auld AF; Alfredo C; Macassa E; Jobarteh K; Shiraishi RW; Rivadeneira ED; Houston J; Spira TJ; Ellerbrock TV; Vaz P
    Pediatr Infect Dis J; 2015 Aug; 34(8):e191-9. PubMed ID: 25955836
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Outcomes of Nigeria's HIV/AIDS Treatment Program for Patients Initiated on Antiretroviral Treatment between 2004-2012.
    Dalhatu I; Onotu D; Odafe S; Abiri O; Debem H; Agolory S; Shiraishi RW; Auld AF; Swaminathan M; Dokubo K; Ngige E; Asadu C; Abatta E; Ellerbrock TV
    PLoS One; 2016; 11(11):e0165528. PubMed ID: 27829033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Retention and Predictors of Attrition Among HIV-infected Children on Antiretroviral Therapy in Côte d'Ivoire Between 2012 and 2016.
    Touré F; Etheredge GD; Brennan C; Parris K; Diallo MO; Ouffoue AF; Ekra A; Prao H; Assamoua NV; Gnongoue C; Kone F; Koffi C; Kamagaté F; Rivadeneira E; Carpenter D
    Pediatr Infect Dis J; 2023 Apr; 42(4):299-304. PubMed ID: 36689665
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results from a rapid national assessment of services for the prevention of mother-to-child transmission of HIV in Côte d'Ivoire.
    Granato SA; Gloyd S; Robinson J; Dali SA; Ahoba I; Aka D; Kouyaté S; Billy DA; Kalibala S; Koné A
    J Int AIDS Soc; 2016; 19(5 Suppl 4):20838. PubMed ID: 27443269
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Task-sharing with nurses to enhance access to HIV treatment in Côte d'Ivoire.
    McNairy ML; Bashi JB; Chung H; Wemin L; Lorng MA; Brou H; Nioble C; Lokossue A; Abo K; Achi D; Ouattara K; Sess D; Sanogo PA; Ekra A; Ettiegne-Traore V; Diabate CJ; Abrams EJ; El-Sadr WM
    Trop Med Int Health; 2017 Apr; 22(4):431-441. PubMed ID: 28101954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High rates of loss to follow-up during the first year of pre-antiretroviral therapy for HIV patients at sites providing pre-ART care in Nigeria, 2004-2012.
    Agolory SG; Auld AF; Odafe S; Shiraishi RW; Dokubo EK; Swaminathan M; Dalhatu I; Onotu D; Abiri O; Debem H; Bashorun A; Ellerbrock TV
    PLoS One; 2017; 12(9):e0183823. PubMed ID: 28863160
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cost-effectiveness of preventing loss to follow-up in HIV treatment programs: a Côte d'Ivoire appraisal.
    Losina E; Touré H; Uhler LM; Anglaret X; Paltiel AD; Balestre E; Walensky RP; Messou E; Weinstein MC; Dabis F; Freedberg KA; ;
    PLoS Med; 2009 Oct; 6(10):e1000173. PubMed ID: 19859538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Wide Variations in Compliance with Tuberculosis Screening Guidelines and Tuberculosis Incidence between Antiretroviral Therapy Facilities - Côte d'Ivoire.
    Auld AF; Blain M; Ekra KA; Kouakou JS; Ettiègne-Traoré V; Tuho MZ; Mohamed F; Shiraishi RW; Sabatier J; Essombo J; Adjorlolo-Johnson G; Marlink R; Ellerbrock TV
    PLoS One; 2016; 11(6):e0157059. PubMed ID: 27275742
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validity of reported retention in antiretroviral therapy after roll-out to peripheral facilities in Mozambique: Results of a retrospective national cohort analysis.
    Lafort Y; Couto A; Sunderbrink U; Hoek R; Shargie E; Zhao J; Viisainen K; Simwaka B
    PLoS One; 2018; 13(6):e0198916. PubMed ID: 29927961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Severe morbidity and mortality in untreated HIV-infected children in a paediatric care programme in Abidjan, Côte d'Ivoire, 2004-2009.
    Desmonde S; Coffie P; Aka E; Amani-Bosse C; Messou E; Dabis F; Alioum A; Ciaranello A; Leroy V
    BMC Infect Dis; 2011 Jun; 11():182. PubMed ID: 21699728
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Decentralizing Access to Antiretroviral Therapy for Children Living with HIV in Swaziland.
    Auld AF; Nuwagaba-Biribonwoha H; Azih C; Kamiru H; Baughman AL; Agolory S; Abrams E; Ellerbrock TV; Okello V; Bicego G; Ehrenkranz P
    Pediatr Infect Dis J; 2016 Aug; 35(8):886-93. PubMed ID: 26849157
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors associated with attrition, mortality, and loss to follow up after antiretroviral therapy initiation: data from an HIV cohort study in India.
    Alvarez-Uria G; Naik PK; Pakam R; Midde M
    Glob Health Action; 2013 Sep; 6():21682. PubMed ID: 24028937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Determinants of loss to follow-up among HIV positive patients receiving antiretroviral therapy in a test and treat setting: A retrospective cohort study in Masaka, Uganda.
    Kiwanuka J; Mukulu Waila J; Muhindo Kahungu M; Kitonsa J; Kiwanuka N
    PLoS One; 2020; 15(4):e0217606. PubMed ID: 32255796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Predictors of loss to follow-up among children in the first and second years of antiretroviral treatment in Johannesburg, South Africa.
    Sengayi M; Dwane N; Marinda E; Sipambo N; Fairlie L; Moultrie H
    Glob Health Action; 2013 Jan; 6():19248. PubMed ID: 23364098
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Costs of Care of HIV-Infected Children Initiating Lopinavir/Ritonavir-Based Antiretroviral Therapy before the Age of Two in Cote d'Ivoire.
    Desmonde S; Avit D; Petit J; Amorissani Folquet M; Eboua FT; Amani Bosse C; Dainguy E; Mea V; Timite-Konan M; Ngbeché S; Ciaranello A; Leroy V
    PLoS One; 2016; 11(12):e0166466. PubMed ID: 27935971
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Survival among antiretroviral-experienced HIV-2 patients experiencing virologic failure with drug resistance mutations in Cote d'Ivoire West Africa.
    Tchounga BK; Charpentier C; Coffie PA; Dabis F; Descamps D; Eholie SP; Ekouevi DK
    PLoS One; 2020; 15(8):e0236642. PubMed ID: 32756581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.